Intention-to-treat analysis revealed no differences in duration of oxygen supplementation at 40 weeks ' postmenstrual age between pentoxifylline ( n = 41 ) and placebo ( n = 40 ) groups ( median 2262 vs 2160 hours , adjusted hazard ratio : 1.14 , 95 % CI 0.72-1 .80 , P = .63 ) .